Metformin is biguanide hypoglycaemia agent used in the treatment of non-insulin-dependent diabetes mellitus (NIDDM) not responding to dietary modification. It is used as a monotherapy or in combination with a sulfonylurea product. In Type 1 diabetic patients or insulin deficient patients, who are not adequately controlled, metformin may be combined with insulin.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
